Cornerstone Counseling Services Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 111 E Midland Rd, Auburn, MI 48611 Phone: 989-266-3422 Fax: 989-266-3197 |
K. H. Counseling And Supervisory Service, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 110 S Auburn Rd, Auburn, MI 48611 Phone: 989-402-0847 |
Serenity Bay Health Pllc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 946 W Midland Rd, Auburn, MI 48611 Phone: 989-266-3188 Fax: 949-561-5532 |
Mindful Matters Child & Adolescent Counseling Services Llc Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 111 E Midland Rd, Auburn, MI 48611 Phone: 989-266-3421 |
Choose Your Change Counseling Llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 110 S Auburn Rd, Auburn, MI 48611 Phone: 989-545-1358 Fax: 989-393-2012 |
News Archive
Stereotaxis, Inc. today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia.
Adheron Therapeutics, a privately held biotechnology company based in Berkeley, California, United States, announced today that it has agreed to be acquired by Roche.
Officials in Connecticut say insurers and families should pick up more bills for mental and developmental health services. In other news, California officials release details for new department of state hospitals and Colorado gets a new assessment of mental health services.
Pregnant women with epilepsy have a more than 10-fold increased risk of death during hospitalisation for delivery, show study findings that suggest the need for increased clinical attention for these pregnancies.
Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.
› Verified 1 days ago